Found 88 with Last Name = 'akasaka' and Initial = 'a' 
Affinity DataIC50: 0.400nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:The compounds of the present invention obtained in the Production Examples were examined for the inhibitory effect on human monoamineoxydase enzymes ...More data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataIC50: 0.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.600nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.700nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.700nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.700nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.900nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.900nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.900nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.900nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 2.70nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.40nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.10nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.70nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 4.70nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 5.10nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 5.40nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 5.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 6.10nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 6.30nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 6.60nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 7.20nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
